PICALM and Alzheimer disease: Among the four markers tested in our data set, only one marker, PICALM (rs3851179) showed nominal significant genotype effects on the change in CDR-SB over time for AD subjects (p = 0.02, Bonferroni adjusted p = 0.08), with the TC genotype showing a greater increase than either the TT or CC genotype.